Oral capecitabine is associated with higher tumor response rates and tolerability than intravenous fluorouracil plus leucovorin for metastatic colorectal cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Oral capecitabine is associated with higher tumor response rates and tolerability than intravenous fluorouracil plus leucovorin for metastatic colorectal cancer'. Together they form a unique fingerprint.